Patients undergoing primary PCI for STEMI who present with moderate or severe fatty liver disease were more likely to have impairment of myocardial perfusion compared with patients with less severe disease, according to recent findings.
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged 8 to 17 years with heterozygous familial hypercholesterolemia.
Women with moderate-to-severe premenstrual syndrome had a 40% increased risk for hypertension later in life compared with women with few or no menstrual symptoms in a recent study.
A small laboratory company, Boston Heart Diagnostics, has introduced and is promoting direct to consumers "the first and only at-home saliva laboratory developed test," which it says will help identify people who are likely to experience side effects from taking a statin.
The combination of statins and beta-blockers before cardiac surgery was associated with lower risk of certain complications afterward, an observational study showed.
In St.petersburg WHO/Europe International Conference on Cardiovascular Diseases was held. Leading experts discussed prevention and control of cardiovascular diseases according to the World and European programmes.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.